Close
American Drug Delivery & Formulation Summit
Xylem

News

LEO Pharma invests in mobile application company

LEO Pharma A/S, a global healthcare company dedicated to helping people achieve healthy skin, invests in privately owned SkinVision B. V., a derma focused mobile app company based in Amsterdam, Netherlands. Ballerup, Denmark, 20 August 2015...

New governance at LEO Pharma and LEO Foundation

Poul Rasmussen will retire at the end of this year as Chairman of LEO Pharma and Chairman of the LEO Foundation. Lars Olsen, Executive Vice President of Global Sales & Marketing at LEO Pharma, will succeed as Chairman of...

LEO Pharma announces new global leadership

LEO Pharma, a global healthcare company dedicated to helping people achieve healthy skin, announces a new global leadership structure and team to support its efforts to help more than 70 million people in 2020. Today,...

LEO Pharma announces new CFO

LEO Pharma, a global healthcare company dedicated to helping people achieve healthy skin, announces Anders Kronborg as EVP Global Finance, IT and Legal. Anders Kronborg will assume the position of Executive Vice President, Global Finance, IT...

Two international scientists awarded for pioneering skin research

The LEO Pharma Research Foundation reveals this yearโ€™s award winners: two talented scientists from Italy and Germany pioneering advances in dermatology research. Today, the LEO Pharma Research Foundation (LPRF) awards two young scientists for their pioneering...

Janssen proudly features artwork, which is displayed and promoted both online and in our buildings around the world, created by people affected by the...

As the door opens to Cliff Enrightโ€™s Manhattan loft, the vibrant watercolor paintings lining the exposed brick wall explode before you in arresting jeweled hues. The intricate white patterns that speckle the paintings appear both painstakingly deliberate yet playfully...

Pivotal Phase 3 Studies of Bezlotoxumab, Merckโ€™s Investigational Antitoxin to Prevent Clostridium Difficile Infection Recurrence, Met Primary Endpoint

Company Plans to Submit New Drug Applications in U.S., EU and Canada in 2015 Results Presented for the First Time at ICAAC/ICC 2015 Annual Meeting known as MSD outside the United States and Canada, today announced...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป